2018
DOI: 10.3889/oamjms.2018.194
|View full text |Cite
|
Sign up to set email alerts
|

Innovative One Step Melanoma Surgical Approach (OSMS): Not a Myth-It’s a Reality! Case Related Analysis of a Patient with a Perfect Clinical Outcome Reported from the Bulgarian Society for Dermatologic Surgery (BULSDS)!

Abstract: BACKGROUND:With the newly described one step melanoma surgical approach, some patient groups could be successfully treated within one surgical session. Depending on the tumour thickness (measured preoperatively) at a later stage (also depending on the ultrasound findings of the locoregional lymph nodes) the respective surgical intervention is planned with the respective field of surgical safety (one-stage melanoma surgery with or without removal of lymph nodes). The innovations could make to some extent some o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
18
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
5

Relationship

4
1

Authors

Journals

citations
Cited by 6 publications
(18 citation statements)
references
References 3 publications
0
18
0
Order By: Relevance
“…If we are guided by the current guidelines, treatment of melanocytic lesions should start with resection with surgical security margins of 0.4-0.5 cm in all directions, followed by postoperative measurement of the tumour thickness and mandatory re-excision planning within short-term deadlines [ 4 ]. Depending on the already established tumour thickness, an assessment should be made at a subsequent or later stage as to the need of re-excision with or without removal of draining lymph nodes [ 4 ]. The question arises inevitably whether it would be appropriate to place the various patients under a common denominator or to individualise the therapy, to be innovative and flexible in our decisions?…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…If we are guided by the current guidelines, treatment of melanocytic lesions should start with resection with surgical security margins of 0.4-0.5 cm in all directions, followed by postoperative measurement of the tumour thickness and mandatory re-excision planning within short-term deadlines [ 4 ]. Depending on the already established tumour thickness, an assessment should be made at a subsequent or later stage as to the need of re-excision with or without removal of draining lymph nodes [ 4 ]. The question arises inevitably whether it would be appropriate to place the various patients under a common denominator or to individualise the therapy, to be innovative and flexible in our decisions?…”
Section: Discussionmentioning
confidence: 99%
“…Through it (based on the experience and individual assessment of clinical, dermatoscopic and ultrasonographic images of lesions and locoregional lymph nodes), an optimal diagnostic evaluation is achieved, as well as a subsequent adequate treatment of cutaneous melanoma [ 3 ]. As a major advantage of this method, we may point out the basic fact that the appropriate patient groups are “spared” from the unnecessary, in some cases, repeated surgical intervention [ 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…In that case, if the therapeutic approach was based on the current guidelines, the treatment should start with a primary excision of the melanocytic lesion with a field of safety of 0.5 cm in all directions followed by postoperative measurement of the tumour thickness [ 4 ]. Depending on the histologically established thickness, during the so-called second stage, an assessment of the reexcision necessity with othe r without removal of the draining lymph nodes has to be performed [ 4 ]. In the case of our patient, the decision for only one initial excision of 1cm in all directions was taken by clinical experience and dermatoscopic data.…”
Section: Discussionmentioning
confidence: 99%
“…Based on the established guidelines, treatment begins with resection of the melanocytic lesion with a surgical margin of 0.4-0.5 cm in all directions, followed by re-excision (as in our patient) with or without parallel drainage lymph node (depending on the established postoperative tumor thickness), which however is not individualized and often leads to ambiguity and hesitation, and hence to difficulty in choosing a therapeutic approach, as in the patient we described. [ 30 ]. The role of SUNN (sentinel lymph node biopsy) continues to be studied, and its use is currently recommended for Stage IB and Stage II melanomas [ 29 ].…”
Section: Discussionmentioning
confidence: 99%